Page last updated: 2024-10-22

aminoglutethimide and Ureteral Obstruction

aminoglutethimide has been researched along with Ureteral Obstruction in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research Excerpts

ExcerptRelevanceReference
" Drug intervention should be on a regular schedule--avoid prn dosage of pain medications."1.27Dilemmas in managing prostate carcinoma (Part II): Metastatic disease. ( Ahmann, FR, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmann, FR1

Other Studies

1 other study available for aminoglutethimide and Ureteral Obstruction

ArticleYear
Dilemmas in managing prostate carcinoma (Part II): Metastatic disease.
    Geriatrics, 1985, Volume: 40, Issue:9

    Topics: Aged; Aminoglutethimide; Aspirin; Bone Neoplasms; Castration; Diethylstilbestrol; Disseminated Intra

1985